跳转至内容
Merck

26454

Sigma-Aldrich

硬脂酸镁

puriss., meets analytical specification of Ph. Eur., BP, ≥90% stearic and palmitic acid basis, ≥40% stearic acid basis (GC), 4.0-5.0% Mg basis (calc on dry sub.)

别名:

十八酸 镁盐

登录查看公司和协议定价


About This Item

线性分子式:
[CH3(CH2)16CO2]2Mg
CAS号:
分子量:
591.24
Beilstein:
3919702
EC號碼:
MDL號碼:
分類程式碼代碼:
12352106
PubChem物質ID:
NACRES:
NA.22

等級

puriss.

化驗

≥40% stearic acid basis (GC)
≥90% stearic and palmitic acid basis
4.0-5.0% Mg basis (calc on dry sub.)

品質

meets analytical specification of Ph. Eur., BP

雜質

acidity or alkalinity, complies
microbiological impurity, in accordance
residual solvents, complies

損耗

≤6.0% loss on drying, 105 °C

mp

200 °C (lit.)

酸價

195‑210(fatty acid)

溶解度

alcohol: insoluble
diethyl ether: insoluble
water: insoluble

負離子痕跡

chloride (Cl-): ≤1000 mg/kg
sulfate (SO42-): ≤5000 mg/kg

正離子痕跡

Cd: ≤3 mg/kg
Ni: ≤5 mg/kg
Pb: ≤10 mg/kg

適合性

in accordance for fatty acid composition
passes test for identity

應用

pharmaceutical (small molecule)

SMILES 字串

CCCCCCCCCCCCCCCCCC(=O)O[Mg]OC(=O)CCCCCCCCCCCCCCCCC

InChI

1S/2C18H36O2.Mg/c2*1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;/h2*2-17H2,1H3,(H,19,20);/q;;+2/p-2

InChI 密鑰

HQKMJHAJHXVSDF-UHFFFAOYSA-L

正在寻找类似产品? 访问 产品对比指南

應用

硬脂酸镁已被用作片剂和胶囊润滑剂。也用于制备微囊。

生化/生理作用

硬脂酸镁是硬脂酸的镁盐,具有润滑性能,因此在将化学粉末压制成固体片剂时可防止成分粘在制造设备上。用硬脂酸镁干包衣可改善流动性、改善流动性和润滑效果、可压片性以及不受抑制的溶出度。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

nwg

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

其他客户在看

M J Amorim et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 52(1), 39-44 (2001-07-05)
Several different peptides and proteins, such as the pancreatic trypsin inhibitor, growth factors and trefoil peptides, are known to play important roles in maintaining the structure and function of the gastrointestinal wall. With the advent of recombinant biotechnology, it has
<BIG>Marleen de Veij</BIG>
Journal of Raman Spectroscopy, 40 (2008)
Ziyaur Rahman et al.
International journal of pharmaceutics, 475(1-2), 462-470 (2014-09-01)
Clinical performance of an amorphous solid dispersion (ASD) drug product is related to the amorphous drug content because of the greater bioavailability of this form of the drug than its crystalline form. Therefore, it is paramount to monitor the amorphous
A Kluk et al.
International journal of pharmaceutics, 485(1-2), 1-6 (2015-03-05)
Minitablets are a novel, multi-compartment solid drug formulation, particularly intended for children between 1 and 6 years of age. Available literature shows that even infants are capable of swallowing a single minitablet. In this study, we have explored the level
Julia Grund et al.
International journal of pharmaceutics, 469(1), 94-101 (2014-04-22)
The objective of this study was to identify and evaluate key polymer properties affecting direct compression and drug release from water-insoluble matrices. Commonly used polymers, such as Kollidon(®) SR, Eudragit(®) RS and ethyl cellulose, were characterized, formulated into tablets and

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门